Coverage
-
June 21, 2019
A Virginia federal judge on Friday combined several class actions accusing Janssen Biotech of monopolizing sales of cancer drug Zytiga and sent them to New Jersey, saying not only does the case belong there but she doesn't want to overcrowd the Old Dominion court's docket.
2 other articles on this case.
View all »